[HTML][HTML] Considerations for diagnostic COVID-19 tests

O Vandenberg, D Martiny, O Rochas… - Nature Reviews …, 2021 - nature.com
During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design,
development, validation, verification and implementation of diagnostic tests were actively …

Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

[HTML][HTML] SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

A Rostami, M Sepidarkish, MMG Leeflang… - Clinical Microbiology …, 2021 - Elsevier
Objectives COVID-19 has been arguably the most important public health concern
worldwide in 2020, and efforts are now escalating to suppress or eliminate its spread. In this …

Immunity to SARS‐CoV‐2 induced by infection or vaccination

X Castro Dopico, S Ols, K Loré… - Journal of internal …, 2022 - Wiley Online Library
Adaptive immune responses play critical roles in viral clearance and protection against re‐
infection, and SARS‐CoV‐2 is no exception. What is exceptional is the rapid …

Review of current COVID-19 diagnostics and opportunities for further development

Y Mardian, H Kosasih, M Karyana, A Neal… - Frontiers in …, 2021 - frontiersin.org
Diagnostic testing plays a critical role in addressing the coronavirus disease 2019 (COVID-
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …

Microfluidic immunoassays for sensitive and simultaneous detection of IgG/IgM/antigen of SARS-CoV-2 within 15 min

Q Lin, D Wen, J Wu, L Liu, W Wu, X Fang… - Analytical …, 2020 - ACS Publications
The outbreak of SARS-CoV-2 is posing serious global public health problems. Facing the
emergence of this pandemic, we established a portable microfluidic immunoassay system …

Functionalized TiO2 Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2

BS Vadlamani, T Uppal, SC Verma, M Misra - Sensors, 2020 - mdpi.com
The COronaVIrus Disease (COVID-19) is a newly emerging viral disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Rapid increase in the …

Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium

D Steensels, E Oris, L Coninx, D Nuyens, ML Delforge… - Jama, 2020 - jamanetwork.com
Methods| From April 22, 2020, to April 30, 2020, all persons who worked at Hospital East-
Limburg (including clinical and nonclinical staff and volunteers) were invited for serologic …

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays …

T Nicol, C Lefeuvre, O Serri, A Pivert, F Joubaud… - Journal of Clinical …, 2020 - Elsevier
Background The emergence of new SARS-CoV-2 has promoted the development of new
serological tests that could be complementary to RT-PCR. Nevertheless, the assessment of …

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)

C Li, C Zhao, J Bao, B Tang, Y Wang, B Gu - Clinica Chimica Acta, 2020 - Elsevier
Abstract The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of …